RADIATION-THERAPY FOR RENAL-TRANSPLANT REJECTION REFRACTORY TO PULSE STEROIDS AND OKT3

被引：0
作者：
RODRIGUEZ, R
NOYES, W
BELZER, F
KINSELLA, T
机构：
[1] UNIV WISCONSIN HOSP,DEPT SURG,MADISON,WI 53792
[2] UNIV WISCONSIN HOSP,DEPT HUMAN ONCOL,MADISON,WI 53792
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1993年 / 27卷
关键词：
D O I：
10.1016/0360-3016(93)90932-L
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [41] OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts
    Uchida, K
    Namii, Y
    Tominaga, Y
    Haba, T
    Tanaka, H
    Ichimori, T
    Uemura, O
    Morozumi, K
    Hayashi, S
    Yokoyama, J
    Takagi, H
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1358 - 1359
  • [42] OKT3 PROPHYLAXIS (OKT3-P) IN RENAL-TRANSPLANT (TXP) PATIENTS (PTS) WITH DELAYED GRAFT FUNCTION (ATN)
    COHEN, DJ
    CIANCI, J
    BENVENISTY, AI
    HARDY, MA
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 512 - 512
  • [43] SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL-TRANSPLANT RECIPIENT TREATED WITH OKT3
    HIBBERD, PL
    TOLKOFFRUBIN, NE
    COSIMI, AB
    SCHOOLEY, RT
    ISAACSON, D
    DORAN, M
    DELVECCHIO, A
    DELMONICO, FL
    AUCHINCLOSS, H
    RUBIN, RH
    [J]. TRANSPLANTATION, 1992, 53 (01) : 68 - 72
  • [44] OKT3 RESISTANT REJECTION IN LIVER-TRANSPLANT PATIENTS
    SUTHERLAND, F
    LAZAROVITS, A
    ABOUJAOUDE, M
    GRANT, D
    GHENT, C
    SOMMERAUER, J
    WALL, W
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1413 - 1414
  • [45] PROPHYLACTIC USE OF OKT3 IN IMMUNOLOGICAL HIGH-RISK CADAVER RENAL-TRANSPLANT RECIPIENTS
    SCHROEDER, TJ
    FIRST, MR
    MANSOUR, ME
    ALEXANDER, JW
    PENN, I
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) : 14 - 18
  • [46] Cytomegalovirus preemptive therapy with ganciclovir in renal transplant patients treated with OKT3
    Gomez, E
    deOna, M
    Aguado, S
    Tejada, F
    Nunez, M
    Portal, C
    DiazCorte, C
    Sanchez, E
    Ortega, F
    AlvarezGrande, J
    [J]. NEPHRON, 1996, 74 (02): : 367 - 372
  • [47] THE RISK OF INFECTION FOLLOWING OKT3 AND ANTILYMPHOCYTE GLOBULIN TREATMENT FOR RENAL-TRANSPLANT REJECTION - RESULTS OF A SINGLE CENTER PROSPECTIVELY RANDOMIZED TRIAL
    HESSE, UJ
    WIENAND, P
    BALDAMUS, C
    POLLOK, M
    PICHLMAIER, H
    [J]. TRANSPLANT INTERNATIONAL, 1992, 5 : S440 - S443
  • [48] SYMPTOMATIC CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS GIVEN EITHER MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) OR OKT3 FOR REJECTION PROPHYLAXIS
    BAILEY, TC
    POWDERLY, WG
    STORCH, GA
    MILLER, SB
    DUNKEL, JD
    WOODWARD, RS
    SPITZNAGEL, E
    HANTO, DW
    DUNAGAN, WC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (02) : 196 - 201
  • [49] INTERRELATIONSHIP OF CYTOMEGALOVIRUS (CMV) INFECTION, RENAL-ALLOGRAFT REJECTION AND OKT3 THERAPY
    MURRAY, BM
    REED, K
    VENUTO, RC
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1107 - 1107
  • [50] Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection
    Kamath, S
    Dean, D
    Peddi, VR
    Schroeder, TJ
    Alexander, JW
    Cavallo, T
    First, MR
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1178 - 1180
12345